ARTICLE | Company News
Armada Health Care LLC, Hemispherx sales and marketing update
September 12, 2011 7:00 AM UTC
Armada will market Hemispherx's Alferon N interferon alfa-n3 in the U.S. The injectable formulation of natural interferon (IFN) alpha is approved to treat genital warts. The deal ends Aug. 14, 2013. ...